8/26/2014 - 3:34 PM EST - RepliCel Life Sciences Inc. : announced its operational and financial results for the second quarter ended June 30, 2014. The total comprehensive loss for the three-month periods ended June 30, 2014, was $1,419,137 or $0.03 per basic and diluted share, compared to a total comprehensive loss of $843,123 or $0.02 per basic and diluted share and $1,600,302 for the three and six-month periods ended June 30, 2013. RepliCel Life Sciences Inc.
shares V.RP are trading down $0.01 at $0.52.
